These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
944 related items for PubMed ID: 18607270
21. A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study. Rahimpour S, Nasiri-Toosi M, Khalili H, Ebrahimi-Daryani N, Nouri-Taromlou MK, Azizi Z. J Gastrointestin Liver Dis; 2016 Dec; 25(4):457-464. PubMed ID: 27981301 [Abstract] [Full Text] [Related]
24. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Gelbmann CM, Rümmele P, Wimmer M, Hofstädter F, Göhlmann B, Endlicher E, Kullmann F, Langgartner J, Schölmerich J. Am J Gastroenterol; 2007 Jun 20; 102(6):1221-9. PubMed ID: 17531010 [Abstract] [Full Text] [Related]
25. Four years experience with short term stenting in primary sclerosing cholangitis. Ponsioen CY, Lam K, van Milligen de Wit AW, Huibregtse K, Tytgat GN. Am J Gastroenterol; 1999 Sep 20; 94(9):2403-7. PubMed ID: 10483999 [Abstract] [Full Text] [Related]
27. Colitis-associated sclerosing cholangitis in children: a single centre experience. Noble-Jamieson G, Heuschkel RB, Torrente F, Hadzic N, Zilbauer M. J Crohns Colitis; 2013 Nov 20; 7(10):e414-8. PubMed ID: 23485432 [Abstract] [Full Text] [Related]
28. Investigative MRI cholangiopancreatography for primary sclerosing cholangitis-type lesions in children with IBD. Alexopoulou E, Xenophontos PE, Economopoulos N, Spyridopoulos TN, Papakonstantinou O, Panayotou I, Dimakou K, Roma E, Kelekis NL. J Pediatr Gastroenterol Nutr; 2012 Sep 20; 55(3):308-13. PubMed ID: 22569526 [Abstract] [Full Text] [Related]
29. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Weber C, Kuhlencordt R, Grotelueschen R, Wedegaertner U, Ang TL, Adam G, Soehendra N, Seitz U. Endoscopy; 2008 Sep 20; 40(9):739-45. PubMed ID: 18698533 [Abstract] [Full Text] [Related]
30. Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis. Abarbanel DN, Seki SM, Davies Y, Marlen N, Benavides JA, Cox K, Nadeau KC, Cox KL. J Clin Immunol; 2013 Feb 20; 33(2):397-406. PubMed ID: 23054338 [Abstract] [Full Text] [Related]
35. Severe acute pancreatitis as the presenting symptom of primary sclerosing cholangitis: treatment by endoscopic insertion of a biliary stent. Goldin E, Libson E, Wengrower D, Antal S, Kovacs Z, Rachmilewitz D. Int Surg; 1990 Oct 20; 75(1):58-60. PubMed ID: 2318575 [Abstract] [Full Text] [Related]
36. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. Cox KL, Cox KM. J Pediatr Gastroenterol Nutr; 1998 Nov 20; 27(5):580-3. PubMed ID: 9822326 [No Abstract] [Full Text] [Related]
37. Primary sclerosing cholangitis in children: a long-term follow-up study. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Hepatology; 2003 Jul 20; 38(1):210-7. PubMed ID: 12830004 [Abstract] [Full Text] [Related]
38. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. Zen Y, Grammatikopoulos T, Heneghan MA, Vergani D, Mieli-Vergani G, Portmann BC. Am J Surg Pathol; 2012 Oct 20; 36(10):1555-61. PubMed ID: 22982898 [Abstract] [Full Text] [Related]